Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trans Tasman Agency

This article was originally published in SRA

Executive Summary

Treaty introduced in both parliaments

Treaty introduced in both parliaments

A trans-Tasman Treaty, paving the way for the setting up of a Trans-Tasman Agency, was simultaneously introduced into both the Australian and New Zealand Parliaments on 30 March 20041. The new agency will replace both the Australian Therapeutic Goods Administration and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe), and will be answerable to the governments of both countries. The treaty establishes the governance and accountability arrangements for the new agency and how it will be set up, and provides a framework for the joint regulatory scheme.

References

1. Department of Health and Ageing press release, 30 March 2004, www.health.gov.au

Latest Headlines
See All
UsernamePublicRestriction

Register

PS109952

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel